Market Cap

Galecto, Inc. Market Capitalization:

$50.9 Million

USD as of Jan. 1, 2023

business Galecto, Inc. Company Profile

Galecto, Inc. Main Stock Listing

show_chart NASDAQ: GLTO

Market Capitalization History of Galecto, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $304.61 B
CSL Limited $93.24 B
Regeneron Pharmaceuticals, Inc. $79.53 B
Marinomed Biotech AG $76.72 B
Vertex Pharmaceuticals Incorporated $74.13 B
Sector: Healthcare
Company Market Cap (USD)
UnitedHealth Group $495.37 B
Johnson & Johnson $461.85 B
Lilly $347.61 B
Novo Nordisk $304.61 B
Pfizer $287.63 B

Yearly evolution of Galecto, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $50.9 M -22.08%
Jan. 1, 2022 $65.3 M -80.63%
Jan. 1, 2021 $337.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Galecto, Inc. Categories

Denmark languages Healthcare languages Biotechnology
Denmark Healthcare Denmark Biotechnology

Stocks & Indices

Galecto, Inc. has the following listings and related stock indices.


Stock: NASDAQ: GLTO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.